Research article · 15 Feb 2018
Case reportPublished 28 Aug 2017
Peripartum Cardiomyopathy: Four Case Reports with Different Outcomes
1Department of Pharmacology, Federal University of São Paulo, Paulista Medical School, Brazil; 2Department of Heart and Vessels, Cardiac Surgery Unit, San Camillo Hospital, Rome, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Peripartum cardiomyopathy (PC) represents a rare, life-threatening condition of late pregnancy or early puerperium but, most likely because of its rare incidence, it remains a poorly understood clinical entity. Indeed, its etiology and clinical management, as well as its prognosis, are still debated. The following reports illustrate three consecutive cases referred to our department who were all diagnosed with PC but who followed completely different clinical courses. All cases were represented by young (Case 1: 30 years-old; Case 2: 32 years-old Case 3: 25 years-old; Case 4:28 years-old ), Caucasian, primiparous, female patients without any concomitant comorbidities who were admitted to our department with a severely reduced left ventricular ejection fraction (LVEF). Case 1 was admitted for cardiogenic shock one day after giving birth whereas Case 2, 3 and 4 nearly two months after delivery for decompensated heart failure (HF). Case 1, besides the standard pharmacological and non-pharmacological therapy for acute HF, received a single dose of cabergoline and, within three weeks, she completely recovered. Otherwise, Case 2 received only standard therapy for acute HF and, though not completely, she showed a significant LVEF improvement at the discharge 1 month later. Finally, Case 3, whose clinical course was complicated by LV thrombosis and arrhythmic storm, underwent to urgent heart transplantation procedure after nearly two months of hospitalization. Finally Case 4 received standard heart failure therapy, restored completely her cardiac function and recently completed her second pregnancy without any complications. Above described cases support the great heterogeneity in clinical presentation and course of PC and seems to confirm that a delayed diagnosis, as well as LV thrombosis, are among factors strongly associated with a poor outcome.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cardiovascular Therapy: Open Access.
Short communication · 30 Jun 2017
Why is Cardiac Morbidity and Mortality Greater Around Christmas, New Year’s, Monday Mornings and in the Morning Hours: Potential Roles of Unrecognized Ionized Hypomagnesemia and Release of Ceramides?
Short communication · 28 Mar 2017
The calcium paradox due to ca2camp interaction andantihypertensive pharmacotherapy new avenues for drug development
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCardiovascular Therapy: Open Access
- SubjectCardiology
- BylineArticles whose byline prints “Ricotta A”
- BylineArticles whose byline prints “Marzia Cottini”
- BylineArticles whose byline prints “Della Monica PL”
- BylineArticles whose byline prints “Sbaraglia F”
- BylineArticles whose byline prints “Polizzi V”
- BylineArticles whose byline prints “Di Stefano G”
- BylineArticles whose byline prints “Pergolini A”
- BylineArticles whose byline prints “Lappa A”
